UNLIMITED TURBO SHORT - ABBOTT LABORATORIES Share Price

Certificat

DE000PF62UM5

Delayed Deutsche Boerse AG 07:20:46 28/05/2024 BST
4.6 EUR +0.22% Intraday chart for UNLIMITED TURBO SHORT - ABBOTT LABORATORIES
Current month+3.15%
1 month+6.99%
Date Price Change
28/05/24 4.6 +0.22%
27/05/24 4.59 0.00%
24/05/24 4.59 +0.88%
23/05/24 4.55 +0.66%
22/05/24 4.52 -3.21%

Delayed Quote Deutsche Boerse AG

Last update May 28, 2024 at 07:20 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PF62UM
ISINDE000PF62UM5
Date issued 18/02/2021
Strike 153.1 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.74
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.48
Lowest since issue 1.89
Spread 0.05
Spread %1.08%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104 USD
Average target price
125.7 USD
Spread / Average Target
+20.92%
Consensus